Circulating Cytotoxic T Lymphocytes Associated Antigen-4 (CTLA-4) Levels and CTLA-4 Gene Polymorphism Role in Head and Neck Squamous Cell Carcinoma
Wiadomości Lekarskie · 2025
DOI: 10.36740/wlek/214629 ↗Kurz gefasst
Fachartikel in der Zeitschrift Wiadomości Lekarskie, 2025. Verfasst von Hiba Hadi Rashid und 4 weiteren Autor:innen. Beteiligte Einrichtung: DEPARTMENT OF MICROBIOLOGY, COLLEGE OF MEDICINE, UNIVERSITY OF DIYALA, DIYALA, IRAQ. Hauptthemen laut MEDLINE: CTLA-4 Antigen, Head and Neck Neoplasms, Squamous Cell Carcinoma of Head and Neck.
Abstract (Originalsprache)
Aim
Aim: To determine the function of soluble CTLA-4 and the CTLA-4+49A/G gene polymorphism in patients with head and neck squamous cell carcinoma. Material and methods Materials and Methods: The current study recruited 180 subjects (90 patients with HNSCCs and comparable number apparently healthful persons as reference) from February 2024 to February 2025.These subjects selected from Medical City, Baghdad, Iraq. All individuals' genomic DNA was extracted from blood samples. To evaluate soluble (sCTLA-4), an enzyme-linked immunoassay kit was used. The Tetra-Primer Amplification Refractory System-Polymerase Chain Reaction (T-ARMS-PCR) was used to genotype and amplification of the CTLA-4 gene using specific primers.
Results
Results: As opposed to controls (median = 389.5 ng/ml, range = 160-1966 ng/ml), the median serum level of sCTLA-4 in patients was 1593.5 ng/ml (range = 1118-2000 ng/ml), which was noticeably higher. There was a significant difference (p=0.024) in the frequency of patients with the AA genotype compared to those did not (67.78% vs. 50%). Conversely, controls had a significantly higher frequency of the heterozygous genotype (AG) than patients (37.78% vs. 28.89%) (OR= 0.20, 95%CI=0.05-0.76, p=0.018). At allelic level, G allele was far more frequent in controls than patients (31.11% versus 17.78%).
Conclusions
Conclusion: The G allele and the heterozygous genotype (AG) may be regarded as protective factors from HNSCC, and AA genotype is risk factor for HNSCC. Soluble CTLA-4 rise remarkably in patients with HNSCC suggesting a function for this protein in pathogenesis of this disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- DEPARTMENT OF MICROBIOLOGY, COLLEGE OF MEDICINE, UNIVERSITY OF DIYALA, DIYALA, IRAQ.
- DEPARTMENT OF MICROBIOLOGY, COLLEGE OF MEDICINE, TIKRIT UNIVERSITY, TIKRIT, IRAQ.
- COLLEGE OF PHARMACY, UNIVERSITY OF AL MAARIF, COLLEGE OF PHARMACY, UNIVERSITY OF AL MAARIF, AL ANBAR, IRAQ.
- AL-AMAL NATIONAL HOSPITAL, BAGHDAD CITY COMPLEX, MINISTRY OF HEALTH ENVIRONMENT, BAGHDAD, IRAQ.
- DEPARTMENT OF RADIATION ONCOLOGY, BAGHDAD RADIATION ONCOLOGY AND NUCLEAR MEDICINE CENTER, BAGHDAD MEDICAL CITY COMPLEX, MINISTRY OF HEALTH ENVIRONMENT, BAGHDAD, IRAQ.
Zitieren
APA
Rashid, H. H., Farhan, R. K., Khaleq, M. A. A., Raof, Y. S., & Sulaiman, A. A. (2025). Circulating Cytotoxic T Lymphocytes Associated Antigen-4 (CTLA-4) Levels and CTLA-4 Gene Polymorphism Role in Head and Neck Squamous Cell Carcinoma. Wiadomości Lekarskie. https://doi.org/10.36740/wlek/214629
Vancouver
Rashid HH, Farhan RK, Khaleq MAA, Raof YS, Sulaiman AA. Circulating Cytotoxic T Lymphocytes Associated Antigen-4 (CTLA-4) Levels and CTLA-4 Gene Polymorphism Role in Head and Neck Squamous Cell Carcinoma. Wiadomości Lekarskie. 2025. doi:10.36740/wlek/214629
BibTeX
@article{Rashid2025,
author = {Rashid, Hiba Hadi and Farhan, Rafal Khaleel and Khaleq, Maysaa Ali Abdul and Raof, Yaala Saady and Sulaiman, Awf Abdulrahman},
title = {Circulating Cytotoxic T Lymphocytes Associated Antigen-4 (CTLA-4) Levels and CTLA-4 Gene Polymorphism Role in Head and Neck Squamous Cell Carcinoma},
journal = {Wiadomości Lekarskie},
year = {2025},
doi = {10.36740/wlek/214629}
}
EUVIMED